Back
Amicus Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
FOLD
Amicus Therapeutics
Last Price:
9.68
Seasonality Move:
7.75%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.76 | Sell |
| 20-day SMA: | 10.65 | Sell |
| 50-day SMA: | 10.81 | Sell |
| 200-day SMA: | 10.98 | Sell |
| 8-day EMA: | 9.84 | Sell |
| 20-day EMA: | 10.35 | Sell |
| 50-day EMA: | 10.71 | Sell |
| 200-day EMA: | 11.01 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 32.67 | Sell |
| Chaikin Money Flow: | 481094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.02 - 11.72) | Sell |
| Bollinger Bands (100): | (10.17 - 11.55) | Sell |
Amicus Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 9.66 while FOLD 8-day simple moving average is 9.76, which is a Sell signal.
- The stock price of FOLD is 9.66 while Amicus Therapeutics 20-day SMA is 10.65, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 10.81 while FOLD share price is 9.66, making it a Sell technically.
- FOLD stock price is 9.66 and Amicus Therapeutics 200-day simple moving average is 10.98, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
29
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $9.66. The Score for FOLD is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.89B
Price in USD:
9.66
Share Volume:
1.92M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
29
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 9.66 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 9.66 while FOLD 8-day exponential moving average is 9.84, which is a Sell signal.
- The stock price of FOLD is 9.66 while Amicus Therapeutics 20-day EMA is 10.35, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 10.71 while FOLD share price is 9.66, making it a Sell technically.
- FOLD stock price is 9.66 and Amicus Therapeutics 200-day simple moving average is 11.01, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 32.67, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (10.02 - 11.72), which suggest Amicus Therapeutics is a Sell
- The Bollinger Bands (100) for Amicus Therapeutics is (10.17 - 11.55), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.